Middle East and Africa Histopathology Services Market Segments and Growth by 2028

The Middle East and Africa histopathology services market is expected to reach US$ 1,597.53 million by 2028 from US$ 1,151.52 million in 2021; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028.

Factors such as strategic alliances among market players and the increasing prevalence of chronic diseases drive the market growth. However, limitations associated with histopathology and immunohistochemistry hinder the histopathology services market growth in the Middle East and Africa.

Cardiovascular disorders, neurological disorders, autoimmune disorders, cancer, and other chronic diseases are the leading causes of death and disabilities worldwide. Rapid changes in lifestyles, and surge in the consumption of alcohol and tobacco products are among the prominent factors triggering the incidence of cancer among populations. Autoimmune diseases further contribute to disorders among a considerable number of people. However, increasing research activities to develop effective treatments for these diseases are boosting the Middle East histopathology services market growth. Researchers and therapists exploring therapies for these diseases conduct detailed histopathological analyses to understand the disease mechanisms, which assist in the designing of therapies for their management. Thus, the rising number of chronic diseases worldwide are fueling the histopathological services market growth. Further, technological developments are allowing medical professionals to upgrade their existing diagnostic procedures and protocols. Innovations in instrumentation, visualization tools, and invasion techniques are bringing improvements along with greater accuracy in diseases diagnoses. Further, strategic alliances between leading and emerging market players to support the promising studies for advanced histopathological analyses are likely to serve significant future trends in the market.

The COVID-19 pandemic has aggravated challenges for the Middle East and Africa. The disease has spread in countries such as Cameroon, Egypt, Algeria, Morocco, South Africa, Togo, Nigeria, Senegal, and Tunisia. African countries are already overwhelmed due to weak healthcare systems. The lack of laboratory capacities and medical supplies make the diagnosis of COVID-19 further challenging. To defeat this challenge, the World Health Organization (WHO) helped 36 African countries with the supply of virus testing kits. Also, they are training and providing personal shielding equipment to health workers in Africa.

 

MIDDLE EAST AND AFRICA HISTOPATHOLOGY SERVICES MARKET SEGMENTATION

By Type of Examination

• Surgical Specimen
• Breast Biopsy
• Lung Biopsy
• Renal Biopsy
• Gastrointestinal Biopsy
• Pancreatic Biopsy
• Skin Tissue Biopsy
• Testicular Biopsy
• Others

By End User

• Diagnostic Laboratories & Reference Laboratories
• Research Institutes
• Others

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Company Profiles

• TPL Path Labs
• UNILABS
• Targos
• CHARLES RIVER LABORATORIES, INC.

Middle East and Africa Histopathology Services Report Scope